These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8656943)

  • 21. Apolipoprotein E Genotyping in Alzheimer's Disease. Chicago, Illinois, October 21-22, 1995. Proceedings.
    Ann N Y Acad Sci; 1996 Dec; 802():1-224. PubMed ID: 9012314
    [No Abstract]   [Full Text] [Related]  

  • 22. Apolipoprotein E genotyping for Alzheimer's disease: ethical concerns and implications for clinical practice.
    Abyad A; al Imad R
    J Med Liban; 1999; 47(5):291-4. PubMed ID: 10887530
    [No Abstract]   [Full Text] [Related]  

  • 23. Apolipoprotein E genotyping in Alzheimer's disease.
    Humphries S; Betteridge DJ; Durrington PN; Galton DJ; Nicholls P
    Lancet; 1996 Jun; 347(9017):1776. PubMed ID: 8656945
    [No Abstract]   [Full Text] [Related]  

  • 24. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.
    Mayeux R; Saunders AM; Shea S; Mirra S; Evans D; Roses AD; Hyman BT; Crain B; Tang MX; Phelps CH
    N Engl J Med; 1998 Feb; 338(8):506-11. PubMed ID: 9468467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NIA/AIzA Conference on apolipoprotein E genotyping in Alzheimer's disease. Bibliography.
    Kwon YJ; Tsai J; Relkin NR
    Ann N Y Acad Sci; 1996 Dec; 802():177-224. PubMed ID: 9012315
    [No Abstract]   [Full Text] [Related]  

  • 27. [Importance of molecular diagnostics in Alzheimer dementia. A case report].
    Honneth J; Nehen HG; Haseke J
    Z Gerontol Geriatr; 2010 Jun; 43(3):177-9. PubMed ID: 20354860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease.
    Ballard C; Holmes C; McKeith I; Neill D; O'Brien J; Cairns N; Lantos P; Perry E; Ince P; Perry R
    Am J Psychiatry; 1999 Jul; 156(7):1039-45. PubMed ID: 10401449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic evidence that the Lewy body variant is indeed a phenotypic variant of Alzheimer's disease.
    Katzman R; Galasko D; Saitoh T; Thal LJ; Hansen L
    Brain Cogn; 1995 Aug; 28(3):259-65. PubMed ID: 8546853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of apolipoprotein E testing in the diagnosis of Alzheimer's disease.
    Galasko D
    West J Med; 1998 Apr; 168(4):264-5. PubMed ID: 9584668
    [No Abstract]   [Full Text] [Related]  

  • 31. Diffuse Lewy body disease.
    Kosaka K
    Intern Med; 1998 Jan; 37(1):6-10. PubMed ID: 9510392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Apolipoprotein E and Alzheimer's disease].
    Lahoz C; Ordovás JM
    Rev Clin Esp; 1997 Feb; 197(2):73-4. PubMed ID: 9213859
    [No Abstract]   [Full Text] [Related]  

  • 33. Midlife smoking, apolipoprotein E and risk of dementia and Alzheimer's disease: a population-based cardiovascular risk factors, aging and dementia study.
    Rusanen M; Rovio S; Ngandu T; Nissinen A; Tuomilehto J; Soininen H; Kivipelto M
    Dement Geriatr Cogn Disord; 2010; 30(3):277-84. PubMed ID: 20847559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease.
    Kakulas BA; Wilton SD; Fabian VA; Jones TM
    Lancet; 1996 Aug; 348(9025):483. PubMed ID: 8709818
    [No Abstract]   [Full Text] [Related]  

  • 35. Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease.
    Smith AD; Jobst KA; Johnston C; Joachim C; Nagy Z
    Lancet; 1996 Aug; 348(9025):483-4. PubMed ID: 8709819
    [No Abstract]   [Full Text] [Related]  

  • 36. Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: a cautionary view.
    Bird TD
    Ann Neurol; 1995 Jul; 38(1):2-4. PubMed ID: 7611719
    [No Abstract]   [Full Text] [Related]  

  • 37. Apolipoprotein-E genotyping in Alzheimer's disease and frontotemporal dementia.
    Gustafson L; Abrahamson M; Grubb A; Nilsson K; Fex G
    Dement Geriatr Cogn Disord; 1997; 8(4):240-3. PubMed ID: 9213069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limitations of using the apolipoprotein E genotype in the diagnosis of Alzheimer's disease.
    Heidenreich W
    J Insur Med; 1998; 30(1):46-7. PubMed ID: 10186439
    [No Abstract]   [Full Text] [Related]  

  • 39. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.
    Polvikoski T; Sulkava R; Haltia M; Kainulainen K; Vuorio A; Verkkoniemi A; Niinistö L; Halonen P; Kontula K
    N Engl J Med; 1995 Nov; 333(19):1242-7. PubMed ID: 7566000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.
    Gavett BE; John SE; Gurnani AS; Bussell CA; Saurman JL
    J Alzheimers Dis; 2016; 49(2):531-45. PubMed ID: 26444761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.